Testing effectiveness (Phase 2)Looking for participantsNCT06831136
What this trial is testing
Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
Who this might be right for
Pancreatic Ductal Adenocarcinoma
The University of Texas Health Science Center, Houston 24